1. Home
  2. EXEL vs AIT Comparison

EXEL vs AIT Comparison

Compare EXEL & AIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • AIT
  • Stock Information
  • Founded
  • EXEL 1994
  • AIT 1923
  • Country
  • EXEL United States
  • AIT United States
  • Employees
  • EXEL N/A
  • AIT N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • AIT Industrial Machinery/Components
  • Sector
  • EXEL Health Care
  • AIT Industrials
  • Exchange
  • EXEL Nasdaq
  • AIT Nasdaq
  • Market Cap
  • EXEL 9.7B
  • AIT 9.8B
  • IPO Year
  • EXEL 2000
  • AIT N/A
  • Fundamental
  • Price
  • EXEL $36.20
  • AIT $257.33
  • Analyst Decision
  • EXEL Buy
  • AIT Strong Buy
  • Analyst Count
  • EXEL 17
  • AIT 8
  • Target Price
  • EXEL $35.50
  • AIT $284.38
  • AVG Volume (30 Days)
  • EXEL 2.5M
  • AIT 345.2K
  • Earning Date
  • EXEL 02-04-2025
  • AIT 01-29-2025
  • Dividend Yield
  • EXEL N/A
  • AIT 0.57%
  • EPS Growth
  • EXEL 441.02
  • AIT 5.85
  • EPS
  • EXEL 1.55
  • AIT 9.80
  • Revenue
  • EXEL $2,081,598,000.00
  • AIT $4,483,162,000.00
  • Revenue This Year
  • EXEL $20.53
  • AIT $2.45
  • Revenue Next Year
  • EXEL $0.95
  • AIT $5.62
  • P/E Ratio
  • EXEL $23.39
  • AIT $26.26
  • Revenue Growth
  • EXEL 17.31
  • AIT 0.85
  • 52 Week Low
  • EXEL $20.02
  • AIT $170.94
  • 52 Week High
  • EXEL $37.59
  • AIT $282.98
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 58.54
  • AIT 57.95
  • Support Level
  • EXEL $33.05
  • AIT $239.86
  • Resistance Level
  • EXEL $37.59
  • AIT $260.00
  • Average True Range (ATR)
  • EXEL 0.99
  • AIT 5.96
  • MACD
  • EXEL 0.28
  • AIT 1.97
  • Stochastic Oscillator
  • EXEL 69.38
  • AIT 89.06

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About AIT Applied Industrial Technologies Inc.

Applied Industrial Technologies Inc is a distributor of industrial products to the maintenance, repair, and operations market and the original equipment manufacturing industry. Further, the company provides engineering and design services for industrial and fluid power applications. The products include bearings, power transmission components, fluid power components and systems, industrial rubber products, linear motion components, safety products, oilfield supplies, and other industrial and maintenance supplies. The company's reportable segments are; Service Center Based Distribution which derives key revenue, and Engineered Solutions. Geographically, the company derives its key revenue from the United States and the rest from Canada and other countries.

Share on Social Networks: